NexImmune, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.43
|
|
Average Rating
|
3.75
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.69
|
-0.60
|
0.09
|
13.04%
|
|
2022-06-30
|
-0.68
|
-0.69
|
-0.01
|
-1.47%
|
|
2022-03-31
|
-0.70
|
-0.66
|
0.04
|
5.71%
|
|
2021-12-31
|
-0.78
|
-0.69
|
0.09
|
11.54%
|
|
2021-09-30
|
-0.64
|
-0.65
|
-0.01
|
-1.56%
|
|
2021-06-30
|
-0.51
|
-0.54
|
-0.03
|
-5.88%
|
|
2021-03-31
|
-0.66
|
-0.71
|
-0.05
|
-7.58%
|
|
2020-12-31
|
-0.44
|
-1.13
|
-0.69
|
-156.82%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.95
|
|
2021-12-31
|
-2.59
|
|
2020-12-31
|
-5.79
|